Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €16.75 EUR
Change Today -0.025 / -0.15%
Volume 0.0
VIH On Other Exchanges
Symbol
Exchange
Xetra
OTC US
Munich
As of 3:35 PM 03/30/15 All times are local (Market data is delayed by at least 15 minutes).

vib vermoegen ag (VIH) Snapshot

Open
€16.76
Previous Close
€16.77
Day High
€16.97
Day Low
€16.61
52 Week High
02/24/15 - €17.52
52 Week Low
04/14/14 - €12.35
Market Cap
415.1M
Average Volume 10 Days
15.7K
EPS TTM
€1.11
Shares Outstanding
24.8M
EX-Date
07/2/15
P/E TM
15.1x
Dividend
€0.48
Dividend Yield
2.69%
Current Stock Chart for VIB VERMOEGEN AG (VIH)

Related News

No related news articles were found.

vib vermoegen ag (VIH) Related Businessweek News

No Related Businessweek News Found

vib vermoegen ag (VIH) Details

VIB Vermögen AG develops, acquires, and manages commercial real estate properties in South Germany. As of December 31, 2013, its real estate portfolio consisted of 98 properties with a total rental area of approximately 893,100 square meters comprising logistics properties, industrial buildings, and shopping and specialist market centres, as well as commercial and service centres. The company was founded in 1993 and is based in Neuburg an der Donau, Germany.

33 Employees
Last Reported Date: 04/17/14
Founded in 1993

vib vermoegen ag (VIH) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

vib vermoegen ag (VIH) Key Developments

Sigma-Aldrich and VIB Partner to Provide Translational Research Tools

Sigma-Aldrich Corporation has announced that its research business unit has formed an alliance with VIB for commercialization and supply of new tools and technologies for translational research. Beginning 2015, Sigma-Aldrich and VIB will collaborate to provide the latest emerging tools and technologies that have demonstrated benefit for translational research and solutions to the challenges that scientists face. Utilizing Sigma-Aldrich's leading R&D and manufacturing capabilities, along with its global distribution network, the alliance will help to accelerate and enhance the commercial development and availability of VIB's research tools and technologies for researchers.

VIB Vermögen AG Reports Earnings Results for the Nine Months of 2014; Confirms Earnings Guidance for the Year 2014

VIB Vermögen AG reported earnings results for the nine months of 2014. The company generated EUR 51.7 million of revenue during the first nine months of the year against EUR 47.9 million a year ago. This 8.0 % year-on-year growth arose particularly from the successful continuation of the company's acquisition and investment strategy. Total operating revenue amounted to EUR 52.3 million during the first nine months against EUR 48.2 million a year ago. Earnings before interest and tax (EBIT) were up by 10.1 % to EUR 40.5 million against EUR 36.8 million a year ago. Earnings before tax (EBIT) improved by 9.3 % year-on-year to reach EUR 25.2 million against EUR 23.0 million a year ago. Consolidated net income of EUR 21.3 million was 10.1 % ahead of the results during the prior-year period of EUR 19.3 million. Earnings per share grew by 1.3 % to EUR 0.81 against EUR 0.80 a year ago. Excluding measurement effects and extraordinary items, the company generated EUR 24.2 million of adjusted EBT during the first nine months of the current financial year EUR 20.4 million a year ago. This further increase of 18.6 % reflects the operating profitability of the company's portfolio. The 8.9 % growth in FFO per share (funds from operations) to EUR 0.86 against EUR 0.79 a year ago underscores the cash flow strength of the business model. Given these good nine-month results, the company is confirming its existing forecast for the full 2014 year, anticipating revenue to lie between EUR 69.0 million and EUR 72.0 million, EBIT between EUR 50.5 million and EUR 52.0 million, and EBT between EUR 29.0 million and EUR 30.5 million (in each case before measurement effects and extraordinary items).

VIB Vermoegen AG Presents at SRC Forum Financials & Real Estate 2014, Sep-10-2014 09:40 AM

VIB Vermoegen AG Presents at SRC Forum Financials & Real Estate 2014, Sep-10-2014 09:40 AM. Venue: Frankfurt, Germany. Speakers: Holger Pilgenrother, Chief Financial Officer and Member of Management Board.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VIH:GR €16.75 EUR -0.025

VIH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for VIH.
View Industry Companies
 

Industry Analysis

VIH

Industry Average

Valuation VIH Industry Range
Price/Earnings 12.8x
Price/Sales 5.7x
Price/Book 1.0x
Price/Cash Flow 12.4x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VIB VERMOEGEN AG, please visit www.vib-ag.de. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.